Karyopharm Therapeutics
Jon Newton is currently serving as the Senior Regional Business Director at Karyopharm Therapeutics Inc. Previously, Jon held various roles in the pharmaceutical industry, including Oncology Portfolio Manager and District Sales Manager at Amgen, Sales Representative at OSI Pharmaceuticals, and Sales Representative at Novartis. Jon has a BA in History from the University of Oklahoma. Throughout their career, Jon has received multiple awards and accolades for their outstanding performance and achievements in sales and leadership.
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).